Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 1/2013

01.01.2013

Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review

verfasst von: Wei Huang, Frederick A. Anderson, Frederick A. Spencer, Alexander Gallus, Robert J. Goldberg

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Venous thromboembolism (VTE) prophylaxis is suboptimal in American hospitals despite long-standing evidence-based recommendations. Data from observational studies indicate a lower uptake of effective prophylaxis in patients hospitalized with medical versus surgical conditions. Reluctance to use prophylaxis in medical patients has been attributed to difficulty in identifying at-risk patients and balancing risks of bleeding against occurrence of VTE. Several risk-assessment models (RAMs) have been proposed to assist physicians in identifying non-surgical patients who need prophylaxis. We conducted a systematic review of published RAMs, based on objective criteria, to determine whether any RAM is validated sufficiently to be employed in clinical practice. We identified 11 RAMs, six derived from primary data and five based on expert opinion. The number, types, and strength of association of VTE risk predictors were highly variable. The variability in methods and outcome measurement precluded pooled estimates of these different models. Published RAMs for VTE lack generalizability and adequate validation. As electronic health records become more ubiquitous, validated dynamic RAMs are needed to assess VTE risk at the point-of-care in real time.
Literatur
1.
Zurück zum Zitat Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW, American College of Chest Physicians (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133(6 Suppl):381S–453SPubMedCrossRef Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW, American College of Chest Physicians (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133(6 Suppl):381S–453SPubMedCrossRef
2.
Zurück zum Zitat Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ (eds) (2006). Hemostasis and thrombosis: basic principles and clinical practice, 5th edn. Lippincott Williams & Wilkins, Philadelphia Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ (eds) (2006). Hemostasis and thrombosis: basic principles and clinical practice, 5th edn. Lippincott Williams & Wilkins, Philadelphia
3.
Zurück zum Zitat Lindblad B, Sternby NH, Bergqvist D (1991) Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 302(6778):709–711PubMedCrossRef Lindblad B, Sternby NH, Bergqvist D (1991) Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 302(6778):709–711PubMedCrossRef
4.
Zurück zum Zitat Sandler DA, Martin JF (1989) Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 82(4):203–205PubMed Sandler DA, Martin JF (1989) Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 82(4):203–205PubMed
5.
Zurück zum Zitat Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG (2005) Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 94(4):750–759PubMed Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG (2005) Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 94(4):750–759PubMed
6.
Zurück zum Zitat Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R, Kalodiki E, Myers K, Samama M, Sasahara A, Cardiovascular Disease Educational and Research Trust and the International Union of Angiology (2001) Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 20(1):1–37PubMedCrossRef Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R, Kalodiki E, Myers K, Samama M, Sasahara A, Cardiovascular Disease Educational and Research Trust and the International Union of Angiology (2001) Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 20(1):1–37PubMedCrossRef
7.
Zurück zum Zitat Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr, ENDORSE Investigators (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371(9610):387–394PubMedCrossRef Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr, ENDORSE Investigators (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371(9610):387–394PubMedCrossRef
8.
Zurück zum Zitat Qaseem A, Chou R, Humphrey LL, Starkey M, Shekelle P, Clinical Guidelines Committee of the American College of Physicians (2011) Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 155(9):625–632PubMed Qaseem A, Chou R, Humphrey LL, Starkey M, Shekelle P, Clinical Guidelines Committee of the American College of Physicians (2011) Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 155(9):625–632PubMed
9.
Zurück zum Zitat Blumenthal D, Tavenner M (2010) The “meaningful use” regulation for electronic health records. N Engl J Med 363(6):501–504PubMedCrossRef Blumenthal D, Tavenner M (2010) The “meaningful use” regulation for electronic health records. N Engl J Med 363(6):501–504PubMedCrossRef
10.
Zurück zum Zitat Menachemi N, Collum TH (2011) Benefits and drawbacks of electronic health record systems. Risk Manag Healthc Policy 4:47–55PubMedCrossRef Menachemi N, Collum TH (2011) Benefits and drawbacks of electronic health record systems. Risk Manag Healthc Policy 4:47–55PubMedCrossRef
11.
Zurück zum Zitat Spencer FA, Emery C, Lessard D, Goldberg RJ, Worcester Venous Thromboembolism Study (2007) Upper extremity deep vein thrombosis: a community-based perspective. Am J Med 120(8):678–684PubMedCrossRef Spencer FA, Emery C, Lessard D, Goldberg RJ, Worcester Venous Thromboembolism Study (2007) Upper extremity deep vein thrombosis: a community-based perspective. Am J Med 120(8):678–684PubMedCrossRef
12.
Zurück zum Zitat Spyropoulos AC (2009) Upper vs. lower extremity deep vein thrombosis: outcome definitions of venous thromboembolism for clinical predictor rules or risk factor analyses in hospitalized patients. J Thromb Haemost 7(6):1041–1042PubMedCrossRef Spyropoulos AC (2009) Upper vs. lower extremity deep vein thrombosis: outcome definitions of venous thromboembolism for clinical predictor rules or risk factor analyses in hospitalized patients. J Thromb Haemost 7(6):1041–1042PubMedCrossRef
13.
Zurück zum Zitat Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52(6):377–384PubMedCrossRef Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52(6):377–384PubMedCrossRef
14.
Zurück zum Zitat The AGREE Collaboration Appraisal of Guidelines for Research and Evaluation (AGREE) instrument training manual (2003) The AGREE Collaboration Appraisal of Guidelines for Research and Evaluation (AGREE) instrument training manual (2003)
15.
Zurück zum Zitat Woller SC, Stevens SM, Jones JP, Lloyd JF, Evans RS, Aston VT, Elliott CG (2011) Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med 124(10):947–954PubMedCrossRef Woller SC, Stevens SM, Jones JP, Lloyd JF, Evans RS, Aston VT, Elliott CG (2011) Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med 124(10):947–954PubMedCrossRef
16.
Zurück zum Zitat Spyropoulos AC, Anderson FA Jr, Fitzgerald G, Decousus H, Pini M, Chong BH, Zotz RB, Bergmann JF, Tapson V, Froehlich JB, Monreal M, Merli GJ, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA, IMPROVE Investigators (2011) Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 140(3):706–714PubMedCrossRef Spyropoulos AC, Anderson FA Jr, Fitzgerald G, Decousus H, Pini M, Chong BH, Zotz RB, Bergmann JF, Tapson V, Froehlich JB, Monreal M, Merli GJ, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA, IMPROVE Investigators (2011) Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 140(3):706–714PubMedCrossRef
17.
Zurück zum Zitat Rothberg MB, Lindenauer PK, Lahti M, Pekow PS, Selker HP (2011) Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med 6(4):202–209PubMedCrossRef Rothberg MB, Lindenauer PK, Lahti M, Pekow PS, Selker HP (2011) Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med 6(4):202–209PubMedCrossRef
18.
Zurück zum Zitat Yale SH, Medlin SC, Liang H, Peters T, Glurich I, Mazza JJ (2005) Risk assessment model for venothromboembolism in post-hospitalized patients. Int Angiol 24(3):250–254PubMed Yale SH, Medlin SC, Liang H, Peters T, Glurich I, Mazza JJ (2005) Risk assessment model for venothromboembolism in post-hospitalized patients. Int Angiol 24(3):250–254PubMed
19.
Zurück zum Zitat Weill-Engerer S, Meaume S, Lahlou A, Piette F, Saint-Jean O, Sachet A, Beinis JY, Gallinari C, Grancher AS, Vincent JP, Naga H, Belmin J, Salvatore R, Kazes M, Pautas E, Boiffin A, Piera JB, Duviquet M, Knafo D, Piau A, Miric D, Jean A, Bellamy V, Tissandier O, Le Blanche AF (2004) Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study. J Am Geriatr Soc 52(8):1299–1304PubMedCrossRef Weill-Engerer S, Meaume S, Lahlou A, Piette F, Saint-Jean O, Sachet A, Beinis JY, Gallinari C, Grancher AS, Vincent JP, Naga H, Belmin J, Salvatore R, Kazes M, Pautas E, Boiffin A, Piera JB, Duviquet M, Knafo D, Piau A, Miric D, Jean A, Bellamy V, Tissandier O, Le Blanche AF (2004) Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study. J Am Geriatr Soc 52(8):1299–1304PubMedCrossRef
20.
Zurück zum Zitat Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG, MEDENOX Study (2004) Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 164(9):963–968PubMedCrossRef Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG, MEDENOX Study (2004) Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 164(9):963–968PubMedCrossRef
21.
Zurück zum Zitat Rocha AT, Paiva EF, Lichtenstein A, Milani R Jr, Cavalheiro CF, Maffei FH (2007) Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag 3(4):533–553PubMed Rocha AT, Paiva EF, Lichtenstein A, Milani R Jr, Cavalheiro CF, Maffei FH (2007) Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag 3(4):533–553PubMed
22.
Zurück zum Zitat McCaffrey R, Bishop M, Adonis-Rizzo M, Williamson E, McPherson M, Cruikshank A, Carrier VJ, Sands S, Pigano D, Girard P, Lauzon C (2007) Development and testing of a DVT risk assessment tool: providing evidence of validity and reliability. Worldviews Evid Based Nurs 4(1):14–20PubMedCrossRef McCaffrey R, Bishop M, Adonis-Rizzo M, Williamson E, McPherson M, Cruikshank A, Carrier VJ, Sands S, Pigano D, Girard P, Lauzon C (2007) Development and testing of a DVT risk assessment tool: providing evidence of validity and reliability. Worldviews Evid Based Nurs 4(1):14–20PubMedCrossRef
23.
Zurück zum Zitat Samama MM, Dahl OE, Mismetti P, Quinlan DJ, Rosencher N, Cornelis M, De Vries H, Van Beusekom I, Kahan JP (2006) An electronic tool for venous thromboembolism prevention in medical and surgical patients. Haematologica 91(1):64–70PubMed Samama MM, Dahl OE, Mismetti P, Quinlan DJ, Rosencher N, Cornelis M, De Vries H, Van Beusekom I, Kahan JP (2006) An electronic tool for venous thromboembolism prevention in medical and surgical patients. Haematologica 91(1):64–70PubMed
24.
Zurück zum Zitat Caprini JA, Arcelus JI, Reyna JJ (2001) Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 38(2 Suppl 5):12–19PubMedCrossRef Caprini JA, Arcelus JI, Reyna JJ (2001) Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 38(2 Suppl 5):12–19PubMedCrossRef
25.
Zurück zum Zitat White RH, Sadeghi B, Tancredi DJ, Zrelak P, Cuny J, Sama P, Utter GH, Geppert JJ, Romano PS (2009) How valid is the ICD-9-CM based AHRQ patient safety indicator for postoperative venous thromboembolism? Med Care 47(12):1237–1243PubMedCrossRef White RH, Sadeghi B, Tancredi DJ, Zrelak P, Cuny J, Sama P, Utter GH, Geppert JJ, Romano PS (2009) How valid is the ICD-9-CM based AHRQ patient safety indicator for postoperative venous thromboembolism? Med Care 47(12):1237–1243PubMedCrossRef
26.
Zurück zum Zitat Clarke A (2002) Length of in-hospital stay and its relationship to quality of care. Qual Saf Health Care 11(3):209–210PubMedCrossRef Clarke A (2002) Length of in-hospital stay and its relationship to quality of care. Qual Saf Health Care 11(3):209–210PubMedCrossRef
27.
Zurück zum Zitat Pabinger I, Ay C (2012) Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis? Hamostaseologie 32(2):132–137 Pabinger I, Ay C (2012) Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis? Hamostaseologie 32(2):132–137
28.
Zurück zum Zitat Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111(10):4902–4907PubMedCrossRef Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111(10):4902–4907PubMedCrossRef
30.
Zurück zum Zitat White RH (2003) The epidemiology of venous thromboembolism. Circulation 107(23 Suppl 1):I4–I8PubMed White RH (2003) The epidemiology of venous thromboembolism. Circulation 107(23 Suppl 1):I4–I8PubMed
31.
Zurück zum Zitat Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I9–I16PubMed Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I9–I16PubMed
32.
Zurück zum Zitat Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A (1992) The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 152(8):1660–1664PubMedCrossRef Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A (1992) The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 152(8):1660–1664PubMedCrossRef
33.
Zurück zum Zitat The Joint Commission and National Quality Forum (2011) Specifications Manual for National Hospital Inpatient Quality Measures The Joint Commission and National Quality Forum (2011) Specifications Manual for National Hospital Inpatient Quality Measures
34.
Zurück zum Zitat Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ (2012) Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):7S–47SPubMedCrossRef Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ (2012) Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):7S–47SPubMedCrossRef
35.
Zurück zum Zitat Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, Goldhaber SZ (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352(10):969–977PubMedCrossRef Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, Goldhaber SZ (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352(10):969–977PubMedCrossRef
Metadaten
Titel
Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review
verfasst von
Wei Huang
Frederick A. Anderson
Frederick A. Spencer
Alexander Gallus
Robert J. Goldberg
Publikationsdatum
01.01.2013
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 1/2013
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-012-0780-0

Weitere Artikel der Ausgabe 1/2013

Journal of Thrombosis and Thrombolysis 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.